Journal: medRxiv
Article Title: Human RIG-I Antiviral Deficiency Caused by a Dominant-Negative Variant Locked in a Signaling-Inactive State
doi: 10.64898/2026.03.02.26347088
Figure Lengend Snippet: RIG-I G731R is a loss-of-function variant with a dominant negative effect. (A) 5’ppp ds39 RNA induced IFN-β reporter activities after transfection with empty vector (EV), WT RIG-I, and G731R plasmids (50 ng) in HEK293T RIG-I -/- cells (Star Methods) (technical replicates, n=3). (B) hPIV-induced IFN-β reporter luciferase activities for G731R. HEK293T cells were transfected with either the WT or G731R construct or EV along with the IFN-β-Luc reporter and a constitutively expressed Renilla reporter for 6 hours. Cells were then infected with hPIV (MOI 3) for an additional 20 hours before measuring luciferase activity. IFN-β-Luc reporter activity in each condition was first normalized to Renilla and then presented relative to WT RIG-I. Data show means ± SD from 3 independent experiments. Statistical analysis was performed using one-sample t-test. ****, P <0.0001. (C) IFN-β promoter response measured by dual luciferase reporter assay in HEK293T RIG-I -/- cells transfected with a constant amount of WT RIG-I plasmid (50 ng), increasing amount of G731R plasmid (0-500 ng), and 5 nM 5’ppp ds39 RNA. The error bars represent the standard error of the mean (technical replicates, n=3), and the curve represents fitting of the mean data to to obtain the half maximal inhibitory concentration IC 50 . (D) hPIV-induced IFN-β reporter luciferase activities in cells co-transfected with WT RIG-I (5 ng) and increasing doses (5 to 20 ng) of G731R or EV plasmids. IFN-β-Luc reporter activity in each condition was first normalized to Renilla and then shown relative to EV. Data show means ± SD from 3 independent experiments. Statistical analysis was performed using one-sample t-test. ***, P <0.001
Article Snippet: Cells were replated in 96-well plates the next day at 250,000 cells/mL density and transfected with 0, 5, or 50 nM 5’ppp ds39 RNA using Lyovec transfection reagent (InvivoGen).
Techniques: Variant Assay, Dominant Negative Mutation, Transfection, Plasmid Preparation, Luciferase, Construct, Infection, Activity Assay, Reporter Assay, Concentration Assay